The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.
Those who are educated about Hepatitis C know that time is of the essence when it comes to receiving treatment. Unfortunately, some Australians with this virus have to wait a reported six years to see a specialist.
Continue reading »Solving the ongoing challenge of how to test potential liver disease drugs before experimenting on humans, Salk Institute researchers have perfected a system where medications can be tested in mice with mostly human livers.
Continue reading »Thanks to research from Duke University's Institute for Genome Sciences & Policy, scientists have confirmed that some individuals have genetic protection against ribavirin-induced anemia. Since ribavirin is part of the standard Hepatitis C treatment protocol, this discovery will better enable physicians to foretell who can best withstand Hepatitis C therapy.
Continue reading »Although both are required for a healthy immune response, learn why those with inflammation of the liver should favor omega-3 fatty acids over omega-6's.
Continue reading »Park Systems' ultra-modern imaging tool (XE-Bio) gives researchers new insight into the replication process of the Hepatitis C virus. The details revealed by the XE-Bio are likely to inspire new, highly-targeted, Hepatitis C medications.
Continue reading »Itching is a common symptom of Hepatitis C that goes underreported and undertreated. Instead of letting it drive you crazy, learn how home remedies and a physician's prescription pad can help ease your itching.
Continue reading »February is American Heart Month. Since Hepatitis C has been proven to be a risk factor for coronary artery disease, the usual ways to reduce heart disease risk is insufficient for those with the virus. However, there are five strategies specifically for Hepatitis C that can reduce the likelihood of impending cardiac problems.
Continue reading »By strategically interspersing liver cells and other specialized cells on growth plates, researchers have figured out how to grow Hepatitis C outside of the body - a critical tool to develop and test new Hepatitis C treatments.
Continue reading »Slowing down efforts to prevent or cure Hepatitis C, this virus has an uncanny ability to mutate and become resistant to new drugs. By identifying compounds that interfere with Hepatitis C's replication process, scientists at Stanford University have uncovered a potentially new approach for suppressing Hepatitis C that does not appear to be vulnerable to drug resistance.
Continue reading »An isomer of PSI -7851 (a polymerase inhibitor that has already demonstrated encouraging clinical results for Hepatitis C), Pharmasset believes that PSI-7977 would be more potent and better suited for manufacturing. Hence, Pharmasset has initiated a Phase 2a trial to test this substance on treatment naïve participants with Hepatitis C genotype 1.
Continue reading »Inside you'll discover:
You'll also receive the latest news and information to support liver health.
Rest assured, we will not rent your email to anyone.
You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window
